Correction: The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer
Elife
.
2019 Jan 7:8:e44851.
doi: 10.7554/eLife.44851.
Authors
James D Joseph
,
Beatrice Darimont
,
Wei Zhou
,
Alfonso Arrazate
,
Amy Young
,
Ellen Ingalla
,
Kimberly Walter
,
Robert A Blake
,
Jim Nonomiya
,
Zhengyu Guan
,
Lorna Kategaya
,
Steven P Govek
,
Andiliy G Lai
,
Mehmet Kahraman
,
Dan Brigham
,
John Sensintaffar
,
Nhin Lu
,
Gang Shao
,
Jing Qian
,
Kate Grillot
,
Michael Moon
,
Rene Prudente
,
Eric Bischoff
,
Kyoung-Jin Lee
,
Celine Bonnefous
,
Karensa L Douglas
,
Jackaline D Julien
,
Johnny Y Nagasawa
,
Anna Aparicio
,
Josh Kaufman
,
Benjamin Haley
,
Jennifer M Giltnane
,
Ingrid E Wertz
,
Mark R Lackner
,
Michelle A Nannini
,
Deepak Sampath
,
Luis Schwarz
,
Henry Charles Manning
,
Mohammed Noor Tantawy
,
Carlos L Arteaga
,
Richard A Heyman
,
Peter J Rix
,
Lori Friedman
,
Nicholas D Smith
,
Ciara Metcalfe
,
Jeffrey H Hager
PMID:
30614786
PMCID:
PMC6322858
DOI:
10.7554/eLife.44851
No abstract available
Keywords:
cancer biology; human biology; medicine.
© 2019, Joseph et al.
Publication types
Published Erratum